ARTICLE | Company News
Roche, AmorChem deal
August 4, 2014 7:00 AM UTC
Roche partnered with VC fund AmorChem to discover small molecules to treat myotonic muscular dystrophy type 1. Discovery will take place at AmorChem’s medicinal chemistry incubator NuChem Therapeutics...